Trials / Terminated
TerminatedNCT01079104
Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Hepa Wash GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with hepatic dysfunction are known to have a high mortality rate. Hepa Wash(R) is a newly developed liver and renal support system that is based on the use of recycled albumin dialysate. The new system has shown a high detoxification capacity in in-vitro and preclinical studies. The aim of the study is to evaluate the safety and efficacy of the Hepa Wash system in patients with hepatic dysfunction in the intensive care unit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hepa Wash | Intervention frequency: 1-10 treatments (decision of the investigator) Duration of intervention per patient: Treatment until recovery or death (max. 6 weeks) |
| PROCEDURE | Standard Medical Therapy | Standard of care treatment |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2013-08-01
- Completion
- 2013-10-01
- First posted
- 2010-03-02
- Last updated
- 2019-07-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01079104. Inclusion in this directory is not an endorsement.